3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Melanoma
1
Esophageal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Cisplatin
18
pembrolizumab
12
Paclitaxel
9
Carboplatin
9
Radiotherapy
5
Gemcitabine
4
Fluorodeoxyglucose F18
4
Colposcopy
4
Brachytherapy
4
fludarabine
3
durvalumab
3
Surveys and Questionnaires
3
Radiation
3
Flow Cytometry
3
Cyclophosphamide
3
Biopsy
3
Bevacizumab
3
toripalimab
2
fludarabine phosphate
2
atezolizumab
2
aldesleukin
2
adavosertib
2
Zoledronic Acid
2
Topotecan
2
Nivolumab
2
Neoadjuvant Therapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Interleukin-2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Neoplasms
×
High-Intensity Focused Ultrasound Ablation
×
Clear all
NCT04116320
2025-07-14
AM-003
University of Virginia
Phase 1
Terminated
5 enrolled